Wednesday, September 14, 2016

BRIEF-FDA extends PDUFA date for Telotristat Etiprate

* FDA extends PDUFA date for Telotristat Etiprate for the

treatment of Carcinoid Syndrome

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)